ºñħ½ÀÀû »êÀü °Ë»ç ½ÃÀå : ¼¼°è »ê¾÷ ±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ, ¿¹Ãø - Á¦Ç° À¯Çüº°, °Ë»ç ¹æ¹ýº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°, °æÀﺰ(2020-2030³â)
Non-invasive Prenatal Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type, By Test Type, By Method, By Application, By End User, By Region and Competition, 2020-2030F
»óǰÄÚµå : 1719121
¸®¼­Ä¡»ç : TechSci Research
¹ßÇàÀÏ : 2025³â 04¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 183 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,500 £Ü 6,197,000
Unprintable PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 5,500 £Ü 7,574,000
PDF and Excel (Multi-User License) help
PDF ¹× Excel º¸°í¼­¸¦ ±â¾÷ÀÇ ÆÀÀ̳ª ±â°ü¿¡¼­ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ¹× Excel ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,000 £Ü 11,017,000
PDF and Excel (Custom Research License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ¹× Excel ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù. 80½Ã°£ÀÇ ¾Ö³Î¸®½ºÆ® ŸÀÓÀÌ Æ÷ÇԵǾî ÀÖ°í Copy & Paste °¡´ÉÇÑ PPT ¹öÀüµµ Á¦°øµË´Ï´Ù. ªÀº Bespoke ¸®¼­Ä¡ ÇÁ·ÎÁ§Æ® ¼öÇà¿¡ ¸Â´Â ¶óÀ̼±½ºÀÔ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

ºñħ½ÀÀû »êÀü °Ë»ç(NIPT) ¼¼°è ½ÃÀåÀº 2024³â 50¾ï 3,000¸¸ ´Þ·¯·Î Æò°¡µÇ¸ç, 2030³â¿¡´Â 77¾ï 4,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ¿¹Ãø ±â°£ µ¿¾È 7.42%ÀÇ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÌ·¯ÇÑ ¼ºÀåÀÇ ¿øµ¿·ÂÀº À¯Àü¼º Áúȯ¿¡ ´ëÇÑ ÀνÄÀÇ Áõ°¡¿Í º¸´Ù ¾ÈÀüÇÏ°í ºñħ½ÀÀûÀÎ »êÀü ¼±º°°Ë»çÀÇ ´ë¾È¿¡ ´ëÇÑ ¼ö¿ä¿¡ ±âÀÎÇÕ´Ï´Ù. Àü ¼¼°èÀûÀ¸·Î »ê¸ðÀÇ ¿¬·ÉÀÌ °è¼Ó Áõ°¡ÇÔ¿¡ µû¶ó ¿°»öü ÀÌ»ó À§Çèµµ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ¿¡ µû¶ó NIPT°¡ ¼±È£µÇ´Â ¼±º°°Ë»ç ¿É¼ÇÀ¸·Î äÅõǰí ÀÖ½À´Ï´Ù. ÀÌ ±â¼úÀº »ê¸ðÀÇ °£´ÜÇÑ Ç÷¾× »ùÇÃÀ» ÅëÇØ Á¤È®ÇÑ °á°ú¸¦ Á¦°øÇϸç, ¾ç¼ö õÀÚ¿Í °°Àº ħ½ÀÀû ½Ã¼ú°ú °ü·ÃµÈ À§ÇèÀ» Á¦°ÅÇÕ´Ï´Ù. Á¶±â Áø´Ü ÀÌ´Ï¼ÅÆ¼ºê¿¡ ´ëÇÑ Á¤ºÎÀÇ Áö¿ø, ¹Î°£ ÀÇ·á ¼­ºñ½º Á¢±Ù¼ºÀÇ ¹ßÀü, ºü¸¥ °á°úÀÇ ÆíÀǼºÀÌ ½ÃÀåÀ» ´õ¿í °­È­½Ã۰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, AI ±â¹Ý ºÐ¼® ¹× ´ÙÁß ºÐ¼®¹ý °³¹ß°ú °°Àº ±â¼ú Çõ½ÅÀº NIPTÀÇ ¹üÀ§¿Í Á¤È®¼ºÀ» È®´ëÇÏ´Â ÇÑÆí, ÀçÅà °Ë»ç ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ÒºñÀÚ ¼ö¿ä´Â º¸´Ù ȯÀÚ Áß½ÉÀÇ ÀÇ·á ¼­ºñ½º Á¦°ø ¸ðµ¨À» À籸¼ºÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå °³¿ä
¿¹Ãø ±â°£ 2026-2030³â
½ÃÀå ±Ô¸ð : 2024³â 50¾ï 3,000¸¸ ´Þ·¯
½ÃÀå ±Ô¸ð : 2030³â 77¾ï 4,000¸¸ ´Þ·¯
CAGR : 2025-2030³â 7.42%
±Þ¼ºÀå ºÎ¹® »ï¿°»öü
ÃÖ´ë ½ÃÀå ºÏ¹Ì

½ÃÀå ÃËÁø¿äÀÎ

¸ðü ¿¬·ÉÀÇ Áõ°¡¿Í ±×¿¡ µû¸¥ ¿°»öü ÀÌ»ó À§Çèµµ Áõ°¡

ÁÖ¿ä ½ÃÀå °úÁ¦

NIPTÀÇ ÇѰè

ÁÖ¿ä ½ÃÀå µ¿Çâ

¼ÒºñÀÚ Á÷Á¢ °Ë»ç °¡´É ¿©ºÎ

¸ñÂ÷

Á¦1Àå °³¿ä

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå °í°´ÀÇ ¼Ò¸®

Á¦5Àå ¼¼°èÀÇ ºñħ½ÀÀû »êÀü °Ë»ç(NIPT) ½ÃÀå Àü¸Á

Á¦6Àå ºÏ¹ÌÀÇ ºñħ½ÀÀû »êÀü °Ë»ç(NIPT) ½ÃÀå Àü¸Á

Á¦7Àå À¯·´ÀÇ ºñħ½ÀÀû »êÀü °Ë»ç(NIPT) ½ÃÀå Àü¸Á

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ºñħ½ÀÀû »êÀü °Ë»ç(NIPT) ½ÃÀå Àü¸Á

Á¦9Àå ³²¹ÌÀÇ ºñħ½ÀÀû »êÀü °Ë»ç(NIPT) ½ÃÀå Àü¸Á

Á¦10Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ºñħ½ÀÀû »êÀü °Ë»ç(NIPT) ½ÃÀå Àü¸Á

Á¦11Àå ½ÃÀå ¿ªÇÐ

Á¦12Àå ½ÃÀå µ¿Çâ°ú ¹ßÀü

Á¦13Àå ¼¼°èÀÇ ºñħ½ÀÀû »êÀü °Ë»ç(NIPT) ½ÃÀå : SWOT ºÐ¼®

Á¦14Àå Porter's Five Forces ºÐ¼®

Á¦15Àå °æÀï ±¸µµ

Á¦16Àå Àü·«Àû Á¦¾È

Á¦17Àå Á¶»ç ȸ»ç ¼Ò°³ ¹× ¸éÃ¥»çÇ×

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The Global Non-invasive Prenatal Testing (NIPT) Market was valued at USD 5.03 billion in 2024 and is projected to reach USD 7.74 billion by 2030, growing at a CAGR of 7.42% during the forecast period. This growth is driven by increased awareness of genetic disorders and the demand for safer, non-invasive prenatal screening alternatives. As maternal age continues to rise globally, so does the risk of chromosomal abnormalities, prompting wider adoption of NIPT as a preferred screening option. The technology offers accurate results using a simple blood sample from the mother, eliminating risks associated with invasive procedures like amniocentesis. Government support for early diagnostic initiatives, advancements in private healthcare access, and the convenience of rapid results further bolster the market. Additionally, innovations such as AI-based analysis and multiplex assay development are broadening the scope and precision of NIPT, while consumer demand for home-based testing solutions is reshaping delivery models to become more patient-centric.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 5.03 Billion
Market Size 2030USD 7.74 Billion
CAGR 2025-20307.42%
Fastest Growing SegmentTrisomy
Largest MarketNorth America

Key Market Drivers

Rising Maternal Age and Associated Risk of Chromosomal Abnormalities

The trend of delayed motherhood, particularly across Europe, is fueling demand for NIPT. As women increasingly postpone childbirth for career or financial reasons, the average maternal age continues to climb-reaching 30.9 years in England and Wales in 2023, according to the ONS. This age shift is associated with heightened risk for chromosomal anomalies like Down syndrome, Edwards syndrome, and Patau syndrome. NIPT has become the preferred screening method due to its high accuracy, non-invasive nature, and safety for both mother and fetus. The growing maternal population over the age of 35 is particularly inclined to choose NIPT over invasive diagnostic tests. The incorporation of NIPT into public healthcare systems such as the NHS has further increased access, supporting its widespread adoption as part of routine prenatal care.

Key Market Challenges

Limitations of NIPT

Despite its advantages, NIPT faces certain limitations that hinder universal adoption. The possibility of false-positive or false-negative results may lead to unnecessary follow-up procedures or missed diagnoses, undermining patient confidence. Since NIPT is a screening-not diagnostic-tool, positive results must be confirmed through invasive testing methods like amniocentesis or CVS, which may deter some from pursuing initial screening. Additionally, NIPT is largely focused on detecting chromosomal abnormalities and may not identify rare or functional genetic disorders, leaving gaps in comprehensive fetal health assessment. Cost also remains a concern, particularly for patients without insurance coverage or in regions where testing is not publicly funded. The lower sensitivity of NIPT for rare conditions and de novo mutations presents further challenges for families seeking exhaustive genetic insights.

Key Market Trends

Availability of Direct-to-Consumer Tests

The emergence of direct-to-consumer (DTC) NIPT is reshaping the market by expanding accessibility and convenience. These at-home testing options enable individuals to initiate genetic screening without visiting a healthcare provider, promoting early decision-making and broader adoption. DTC models align with the broader movement toward personalized and proactive healthcare, offering users greater control over prenatal care choices. They are especially beneficial for individuals in remote or underserved regions who face barriers to in-clinic services. While concerns over result interpretation and medical oversight remain, the convenience and consumer empowerment offered by DTC NIPT options are expected to drive future demand and innovation within the market.

Key Market Players

Report Scope:

In this report, the Global Non-invasive Prenatal Testing (NIPT) Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Non-invasive Prenatal Testing (NIPT) Market, By Product Type:

Non-invasive Prenatal Testing (NIPT) Market, By Test Type:

Non-invasive Prenatal Testing (NIPT) Market, By Method:

Non-invasive Prenatal Testing (NIPT) Market, By Application:

Non-invasive Prenatal Testing (NIPT) Market, By End User:

Non-invasive Prenatal Testing (NIPT) Market, By Region:

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Non-invasive Prenatal Testing (NIPT) Market.

Available Customizations:

Global Non-invasive Prenatal Testing (NIPT) Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customer

5. Global Non-invasive Prenatal Testing (NIPT) Market Outlook

6. North America Non-invasive Prenatal Testing (NIPT) Market Outlook

7. Europe Non-invasive Prenatal Testing (NIPT) Market Outlook

8. Asia-Pacific Non-invasive Prenatal Testing (NIPT) Market Outlook

9. South America Non-invasive Prenatal Testing (NIPT) Market Outlook

10. Middle East and Africa Non-invasive Prenatal Testing (NIPT) Market Outlook

11. Market Dynamics

12. Market Trends & Developments

13. Global Non-invasive Prenatal Testing (NIPT) Market: SWOT Analysis

14. Porter's Five Forces Analysis

15. Competitive Landscape

16. Strategic Recommendations

17. About Us & Disclaimer

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â